Altered islet homeostasis before classic insulitis in BB rats

Diabetes and Metabolism

Volumn 28, Issue 6 II, 2002, Pages

  Wang, G S ^b   Karamchandani, J ^b   Pulido, O ^b   Rosenberg, L ^b   Scott, F W ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

cell; Apoptosis; BB rat; Cell proliferation; Homeostasis; Neogenesis

Indexed keywords

CYCLINE; CYTOKERATIN 20; GLUCAGON; INSULIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; CONFERENCE PAPER; DIABETES MELLITUS; DIETARY INTAKE; DISEASE PREDISPOSITION; IMMUNOHISTOCHEMISTRY; INSULITIS; NONHUMAN; PANCREAS ISLET BETA CELL; RAT;

ANIMALS; APOPTOSIS; BODY WEIGHT; BROMODEOXYURIDINE; CELL DIVISION; CELL SIZE; CEREALS; DIABETES MELLITUS, TYPE 1; DIET; HOMEOSTASIS; ISLETS OF LANGERHANS; ORGAN SIZE; PANCREAS; PANCREATIC DISEASES; RATS; RATS, INBRED BB;

EID: 12244258220     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Kloppel G, Drenck CR, Oberholzer M, Heitz PU. Morphometric evidence for a striking β-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol, 1984, 403, 441-452.
2. Kloppel G, Drenck CR. Carstensen A, Heitz PU. The β-cell mass at the clinical onset of type 1 diabetes. Behring Inst Mitt, 1984, 75, 42-49.
3. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia, 1984, 26, 456-461.
4. Lohr M, Markholst H, Dyrberg T, Kloppel G, Oberholzer M, Lernmark A. Insulitis and diabetes are preceded by a decrease in beta-cell volume in diabetes-prone BB rats. Pancreas, 1989, 4, 95-100.
5. Montanya E, Nacher V, Biarnes M, Soler J. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy [In Process Citation]. Diabetes, 2000, 49, 1341-1346.
6. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology, 1997, 138, 1736-1741.
7. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W. Polonsky KS. Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes, 1999, 48, 989-996.
8. Kimura T, Ito A, Hancock WW, Maki T. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice. J Autoimmun, 1999, 12, 243-249.
9. Scott FW, Cloutier HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes 1997, 46, 589-598.
10. 14C]glutamine in islets and Peyer's patches, reduces abnormally high mitotic activity in mesenteric lymph nodes, enhances islet insulin and tends to normalize NO production. Int J Exp Diabetes Res, 2000, 1, 121-130.
11. Vinik A, Rafaeloff R, Pittenger G, Rosenberg L, Duguid W. Induction of pancreatic islet neogenesis. Horm Metab Res, 1997, 29, 278-293.
12. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes, 1995, 44, 249-256.
13. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes, 1997, 46, 750-757.
14. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol, 1996, 178, 176-181.
15. Fieldus WE, Field CJ, Finegood DT. Net cell death contributes to remodeling of the β-cell mass in the neonatal BioBreeding rat. Diabetes, 1999, 48, A249.
16. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes, 2000, 49, 1-7.
17. Lally FJ, Ratcliff H, Bone AJ. Apoptosis and disease progression in the spontaneously diabetic BB/S rat. Diabetologia, 2001, 44, 320-324.
18. Bursch W, Lauer B. Timmermann-Trosiener I, Barthel G, Schuppler J. Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 1984, 5, 453-458.
19. Wang GS, Gruber H, Smyth P, Pulido O, Rosenberg L, Duguid W, Scott FW. Hydrolysed casein diet protects diabetes-prone BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun, 2000, 15, 407-416.
20. Lee ES, Jiang J, Sund GC, Simonson WT, Graham J, Dietsch G, Schimpf B, Bieg S, Peterman G, Lernmark A. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes, 1999, 48, 43-49.
21. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes, 1999, 48, 2270-2276.
22. Wang RN, Kloppel G, Bouwens L, Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia, 1995, 38, 1405-1411.
23. O'Reilly LA, Gu D, Sarvetnick N, Edlund H, Phillips JM, Fulford T, Cooke A, alpha-cell neogenesis in an animal model of IDDM. Diabetes, 1997, 46, 599-606.
24. Bouwens L, Wang RN, De Blay E, Pipeleers DG, Kloppel G. Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes, 1994, 43, 1279-1283.
25. Bouwens L, De Blay E. Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem, 1996, 44, 947-951.
26. Fernandes A, King LC, Guz Y, Stein R, Wright CV, Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology, 1997, 138, 1750-1762.
27. Markholst H, Lernmark A. Reduced pancreatic insulin is associated with retarded growth of the pancreas in young prediabetic BB rats. Pancreas, 1988, 3, 140-144.
28. Swenne I, Borg LA, Crace CJ, Schnell Landstrom A. Persistent reduction of pancreatic beta-cell mass after a limited period of protein-energy malnutrition in the young rat. Diabetologia, 1992, 35, 939-945.
29. O'Brien BA, Fieldus WE, Field CJ, Finegood DT. β-cell apoptosis in the neonatal BioBreeding rat. Diabetes, 2000, 49, 1083.
30. Kurrer MO, Pakala SV, Hanson HL, Katz JD. Beta-cell apoptosis in T-cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA, 1997, 94, 213-218.
31. Lohr M, Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia, 1987, 30, 757-762.
32. Contreas G, Jorgensen J, Madsen OD. Novel islet, duct, and acinar cell markers defined by monoclonal autoantibodies from prediabetic BB rats. Pancreas, 1990, 5, 540-547.
33. Ivarsson SA, Marner B, Lernmark A, Nilsson KO. Nonislet pancreatic autoantibodies in sibship with permanent neonatal insulin-dependent diabetes mellitus. Diabetes, 1988, 37, 347-350.
34. Panicot L, Mas E, Thivolet C, Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes, 1999, 48, 2316-2323.
35. Bouwens L, Pipeleers DG. Extra-insular beta-cells associated with ductules are frequent in adult human pancreas. Diabetologia, 1998, 41, 629-633.
36. Wang RN, Bouwens L, Kloppel G. Beta-cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia, 1994, 37, 1088-1096.